Dren Bio Strengthens Leadership Team With Appointment of Amit Mehta, Ph.D., As Chief Operating Officer and Chief Business Officer

Oct 30, 2023•almost 2 years ago

Position

Chief Business Officer

Company

DR-0201

Amit Mehta

Foster CityBiotechnology

Description

Dren Bio, Inc. a clinical-stage biopharmaceutical company developing antibody therapeutics for cancer, autoimmune and other serious diseases, today announced the expansion of its leadership team with the appointment of Amit Mehta, Ph.D., as the Company’s Chief Operating Officer and Chief Business Officer

Company Information

Company

DR-0201

Location

321 GRUNION COURT

Foster City, California, United States

About

DR-0201 is a targeted bispecific myeloid cell engager. It is designed for deep B-cell depletion, particularly in immunology applications. This therapy represents a potential treatment option for diseases like lupus. The acquisition strengthens Sanofi's early pipeline.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months